PT774119E - Moleculas de suporte oligomericas com grupos marcadores e haptenos incorporados de modo selectivo - Google Patents

Moleculas de suporte oligomericas com grupos marcadores e haptenos incorporados de modo selectivo

Info

Publication number
PT774119E
PT774119E PT95927713T PT95927713T PT774119E PT 774119 E PT774119 E PT 774119E PT 95927713 T PT95927713 T PT 95927713T PT 95927713 T PT95927713 T PT 95927713T PT 774119 E PT774119 E PT 774119E
Authority
PT
Portugal
Prior art keywords
marker
groups incorporated
selective mode
support molecules
hapten groups
Prior art date
Application number
PT95927713T
Other languages
English (en)
Inventor
Hans-Peter Josel
Eva Hoss
Andreas Finke
Rupert Herrmann
Andreas Marschall
Christoph Seidel
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4430998A external-priority patent/DE4430998A1/de
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of PT774119E publication Critical patent/PT774119E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
PT95927713T 1994-07-25 1995-07-24 Moleculas de suporte oligomericas com grupos marcadores e haptenos incorporados de modo selectivo PT774119E (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4426276 1994-07-25
DE4430998A DE4430998A1 (de) 1994-07-25 1994-08-31 Metallchelat-markierte Peptide
DE4430973A DE4430973A1 (de) 1994-07-25 1994-08-31 Hapten-markierte Peptide
DE4439345A DE4439345A1 (de) 1994-07-25 1994-11-04 Oligomere Trägermoleküle mit definiert eingebauten Markierungsgruppen und Haptenen

Publications (1)

Publication Number Publication Date
PT774119E true PT774119E (pt) 2004-07-30

Family

ID=27436022

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95927713T PT774119E (pt) 1994-07-25 1995-07-24 Moleculas de suporte oligomericas com grupos marcadores e haptenos incorporados de modo selectivo

Country Status (12)

Country Link
EP (1) EP0774119B1 (pt)
JP (1) JP3923076B2 (pt)
CN (1) CN1178062C (pt)
AT (1) ATE261122T1 (pt)
CA (1) CA2195752C (pt)
DK (1) DK0774119T3 (pt)
ES (1) ES2217282T3 (pt)
FI (1) FI970299A (pt)
NO (1) NO970130L (pt)
NZ (1) NZ290810A (pt)
PT (1) PT774119E (pt)
WO (1) WO1996003650A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030078416A1 (en) * 1996-04-30 2003-04-24 Yitzhak Tor Substituted phenanthrolines
US6081734A (en) 1996-08-16 2000-06-27 Roche Diagnostics Gmbh Monitoring system for the regular intake of a medicament
FR2955111B1 (fr) 2010-01-12 2013-05-31 Biomerieux Sa Procede de preparation de composes polybiotinyles

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE42317T1 (de) * 1983-07-29 1989-05-15 Henning Berlin Gmbh Voraktivierte kunststoffoberflaechen zur immobilisierung von organisch-chemischen und biologischen materialien, verfahren zur herstellung und verwendung derselben.
US4748111A (en) * 1984-03-12 1988-05-31 Molecular Diagnostics, Inc. Nucleic acid-protein conjugate used in immunoassay
EP0155224A3 (en) * 1984-03-15 1987-05-06 CHROMAGENICS, Inc. Solid-borne complex bearing chromagen responsive functionality for antibody, antigen, receptor, or ligand detection
DK365785A (da) * 1984-09-17 1986-03-18 Hoffmann La Roche Metalcomplexer
US5106762A (en) * 1990-04-20 1992-04-21 Georgetown University Ligand-label conjugates which contain polyoxoanions of sulfur or phosphorus
JPH05126829A (ja) * 1991-04-03 1993-05-21 Syntex Usa Inc 免疫グロブリンのイムノアツセイ

Also Published As

Publication number Publication date
CN1153555A (zh) 1997-07-02
ES2217282T3 (es) 2004-11-01
CN1178062C (zh) 2004-12-01
ATE261122T1 (de) 2004-03-15
EP0774119A1 (de) 1997-05-21
CA2195752A1 (en) 1996-02-08
AU682278B2 (en) 1997-09-25
NO970130D0 (no) 1997-01-10
FI970299A0 (fi) 1997-01-24
FI970299A (fi) 1997-01-24
NO970130L (no) 1997-01-10
JPH10506708A (ja) 1998-06-30
CA2195752C (en) 2010-10-26
JP3923076B2 (ja) 2007-05-30
WO1996003650A1 (de) 1996-02-08
AU3164995A (en) 1996-02-22
NZ290810A (en) 1998-01-26
EP0774119B1 (de) 2004-03-03
DK0774119T3 (da) 2004-07-12

Similar Documents

Publication Publication Date Title
ITTO950367A0 (it) Proteine di prrsv ricombinanti, corredi diagnostici e vaccini contenenti tali proteine di prrsv ricombinanti.
DE68917549D1 (de) Glas für Automobilscheibe.
DE69534778D1 (en) Cathepsin-02-protease
BR9005821A (pt) Vidro de silica-cal-soda,vidraca automotiva e unidade de vidraca automotiva
DK0733069T3 (da) Oprensede Primat CTLA-8-antigener og beslægtede reagenser
DE3768492D1 (de) Luftfeder, balg und verfahren.
ATE308554T1 (de) Säugetier-telomerase
DK0807178T3 (da) Mycobaktielle proteiner, mikroorganismer producerende samme og anvendelser af nævnte proteiner i vacciner og til påvisning af tuberkulose
DE69002273D1 (de) Fahrzeuglufttemperierungseinrichtung.
DE68908614D1 (de) Vorrichtung zur Herstellung von gebogenen Glasscheiben.
DE69018537D1 (de) Zweistufiges Verfahren zum Herstellen starker, dünner Schlauchblasfolien.
DE69007018D1 (de) Fahrzeugklimaanlage.
ATE285474T1 (de) Haemophilus adhäsionsproteinen
DE69016245D1 (de) Artikel zur Gewebekonditionierung.
DE69515426D1 (de) Versetzbahres Fahrbahnbegrenzungselement, Fahrbahnbegrenzung damit hergestellt und Verfahren zur Herstellung
DE59009116D1 (de) Versuchsträger.
DE69630008D1 (de) Treponema palladium Fusions-Antigen, Nachweis für Anti-treponema palladium Antikörpern mit diesen Fusions-Antigenen
PT774119E (pt) Moleculas de suporte oligomericas com grupos marcadores e haptenos incorporados de modo selectivo
ES2236703T3 (es) Uso de metodos para identificar oligopeptidos de señal hidrofilos.
DE69013264D1 (de) Zentraldifferential für vierradgetriebenes Kraftfahrzeug.
DE69002175D1 (de) Radialluftreifen.
DE69002190D1 (de) Radialluftreifen.
DE3872648D1 (de) Alkanoylesterverbindungen, zwischenverbindungen dazu und verfahren zur herstellung.
WO1995029245A3 (fr) Proteines du complexe btf2 et leurs applications
WO2005037228A3 (en) Halogen phosphonate monoesters